[ECCO 9 -- Future trends in endocrine therapy of breast cancer].
D000077384:Anastrozole; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004958:Estradiol / Q000031:analogs & derivatives / Q000627:therapeutic use; D004965:Estrogen Antagonists / Q000627:therapeutic use; D005060:Europe; D005260:Female; D000077267:Fulvestrant; D006801:Humans; D019290:Megestrol Acetate / Q000627:therapeutic use; D009570:Nitriles / Q000737:chemistry / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D014230:Triazoles / Q000737:chemistry / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D009570:Nitriles; D014230:Triazoles; D000077267:Fulvestrant; D000077384:Anastrozole; D004958:Estradiol; D019290:Megestrol Acetate